TCM Compound for IBS, Crohn’s Moves into Phase III Testing
By Shannon Ellis
Wednesday, September 18, 2013
SHANGHAI – A joint venture between a Chinese and a Swiss company has launched Phase III trials for a botanical drug to treat inflammatory bowel disease.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.